Risk factors for chronic thromboembolic pulmonary hypertension

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F09%3A910" target="_blank" >RIV/00064165:_____/09:910 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/09:910

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Risk factors for chronic thromboembolic pulmonary hypertension

Popis výsledku v původním jazyce

Chronic thromboembolic pulmonary hypertension (CTEPH) is characterised by nonresolving pulmonary thromboemboli that can be treated by surgical pulmonary endarterectomy (PEA). The authors of the present study sought to confirm known and to identify novelCTEPH risk factors in a controlled retrospective cohort study of prevalent CTEPH collected in three European centres offering PEA. Data from CTEPH patients were compared with nonthromboembolic pre-capillary pulmonary arterial hypertension cohorts at theparticipating institutions. The study population comprised 687 patients assessed at the time of diagnosis between 1996 and 2007.. Thyroid replacement therapy and a history of emerged as novel CTEPH risk factors. In conclusion, the European database studyconfirmed previous knowledge of chronic thromboembolic pulmonary hypertension risk factors, and identified thyroid replacement therapy and a history of malignancy as new medical conditions associated with chronic thromboembolic pulmonary

Název v anglickém jazyce

Risk factors for chronic thromboembolic pulmonary hypertension

Popis výsledku anglicky

Chronic thromboembolic pulmonary hypertension (CTEPH) is characterised by nonresolving pulmonary thromboemboli that can be treated by surgical pulmonary endarterectomy (PEA). The authors of the present study sought to confirm known and to identify novelCTEPH risk factors in a controlled retrospective cohort study of prevalent CTEPH collected in three European centres offering PEA. Data from CTEPH patients were compared with nonthromboembolic pre-capillary pulmonary arterial hypertension cohorts at theparticipating institutions. The study population comprised 687 patients assessed at the time of diagnosis between 1996 and 2007.. Thyroid replacement therapy and a history of emerged as novel CTEPH risk factors. In conclusion, the European database studyconfirmed previous knowledge of chronic thromboembolic pulmonary hypertension risk factors, and identified thyroid replacement therapy and a history of malignancy as new medical conditions associated with chronic thromboembolic pulmonary

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

<a href="/cs/project/NR9224" target="_blank" >NR9224: Úloha cytokinů v perioperačním průběhu chirurgické léčby nemocných s plicní hypertenzí</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2009

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Respiratory Journal

ISSN

0903-1936

e-ISSN

—

Svazek periodika

33

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

7

Strana od-do

—

Kód UT WoS článku

000263709300015

EID výsledku v databázi Scopus

—